XTANDI (Enzalutamide) is a registered trademark of Astellas Pharma.
General Warning: The patient receiving this medication has a high risk of seizure. Generally, no clinical trial is done in a patient having a seizure.
What is Enzalutamide, and how is it used?
It belongs to the androgen receptor inhibitor class drug used in the treatment of prostate cancer. It is used in patients with metastatic castration-resistant prostate cancer who have at least received one private docetaxel therapy. This medicine is used to treat castrate-resistant prostate cancer (CRPC), a stage where prostate cancer keeps growing even when there are very low testosterone levels in the body.
What is Prostate Cancer?
The uncontrollable proliferation of cells in the prostate gland of males causes Prostate cancer. This gland is found only in males that produce some fluid part of semen. Prostate cancer can show metastasis and can spread to other body parts. If a part of the prostate tumor travels through the bloodstream and reaches bone causing abnormal growth in cells of bone, this will be called metastatic prostate cancer rather than bone cancer.
What are the symptoms of prostate cancer?
Some listed symptoms of prostate cancer that could indicate prostate cancer. If anyone appears, the person should immediately consult a doctor. These are:
- The sudden need for urinating
- Weak flow when you urinate
- Difficulty in starting to urinate
- Need to urinate more often.
There are mainly two Prostate cancer stages namely clinical stage and pathologic Staging.
- Clinical Stages: this is based on the result of a Urologist’s physical examination about prostate development and its treatment method.
- Pathologic Staging: after the surgery or prostate cancer treatment the pathologist uses the TNM Staging system to know the spread of further prostate cancer to other organs, bones, or lymph nodes.
How Does Xtandi Work?
The medicine Xtandi works by decreasing androgen production by inhibiting androgen receptors. If the production of androgen is lowered, the cancerous cell does not get enough male hormone to divide continuously, thus stopping its further cell cycle.
How long can you take Enzalutamide?
Enzalutamide can increase survival rate up to 5 months in the late prostate cancer stage when this drug is given continuously it increases the survival rate from 3 months to 8.3 months.
What is XTANDI (Enzalutamide) 40 mg?
XTANDI is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
Enzalutamide Cost: Xtandi FDA approved drug is inexpensive and very economical. Enzalutamide medicine is available at all registered pharmaceutical corporations. One can also order this drug online from any firm website.
Dosage: This drug is available in capsule form of concentration 40 mg. This capsule should not break, chew, or crush. One can take it with or without food.